Exoskeleton Robotic Assisted Gait Training in Spastic Stroke Post Botulinum Toxin A Injection
Spastic Gait, Spastic
About this trial
This is an interventional treatment trial for Spastic Gait focused on measuring Spasticity, Stroke rehabilitation, Botulinum toxin type A injection, Robot, Knee
Eligibility Criteria
Inclusion Criteria: Ischemic or hemorrhagic stroke ≥ 3 months Age ≥ 20 years Functional Ambulation Category ≥4 Affected rectus femoris spasticity (MAS between 1+ and 2) BoNT-A treatment-naive or treated with BoNT-A ≥4 months in the affected leg before recruitment Receiving oral muscle relaxants or other medication for spasticity were on a stable dose for≥2 months Can obey simple order Exclusion Criteria: Pregnant Sensitivity to BoNT-A Infection of the skin, soft tissue in the injection area Participation in other trials Fixed contractures or bony deformities in the affected leg Previous treatment of the affected leg with neurolytic or surgical procedures (i.e., phenol block, tendon lengthening of transfer, tenotomy, muscle release, arthrodesis) Severe cardiovascular comorbidity (i.e., recent myocardial infarction, heart failure, uncontrolled hypertension, orthostatic hypotension)
Sites / Locations
- Department of Rehabilitation, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, TaiwanRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
BoNT-A injection and robot therapy
None BoNT-A injection and robot therapy
Training session included 40 minutes Robotic Therapy, the group will receive 2 sessions per week, for 12 weeks.
Training session included 40 minutes Robotic Therapy, the group will receive 2 sessions per week, for 12 weeks.